Metabolic Syndrome and the Risk for Chronic Kidney Disease among Nondiabetic Adults
The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Abstract
The metabolic syndrome is a risk factor for the development of diabetes and cardiovascular disease; however, no prospective studies have examined the metabolic syndrome as a risk factor for chronic kidney disease (CKD). A total of 10,096 nondiabetic participants who were in the Atherosclerosis Risk in Communities study and had normal baseline kidney function composed the study cohort. The metabolic syndrome was defined according to recent guidelines from the National Cholesterol Education Program. Incident CKD was defined as an estimated GFR (eGFR) <60 ml/min per 1.73 m2 at study year 9 among those with an eGFR > or =60 ml/min per 1.73 m2 at baseline. After 9 yr of follow-up, 691 (7%) participants developed CKD. The multivariable adjusted odds ratio (OR) of developing CKD in participants with the metabolic syndrome was 1.43 (95% confidence interval [CI], 1.18 to 1.73). Compared with participants with no traits of the metabolic syndrome, those with one, two, three, four, or five traits of the metabolic syndrome had OR of CKD of 1.13 (95% CI, 0.89 to 1.45), 1.53 (95% CI, 1.18 to 1.98), 1.75 (95% CI, 1.32 to 2.33), 1.84 (95% CI, 1.27 to 2.67), and 2.45 (95% CI, 1.32 to 4.54), respectively. After adjusting for the subsequent development of diabetes and hypertension during the 9 yr of follow-up, the OR of incident CKD among participants with the metabolic syndrome was 1.24 (95% CI, 1.01 to 1.51). The metabolic syndrome is independently associated with an increased risk for incident CKD in nondiabetic adults.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The metabolic syndrome is also an independent indicator for chronic kidney disease [636] and may be related to liver steatosis [637].”
Citations
Cites
Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280883 · Cited by 31,502
Grundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,947
Levey, A. S., Bosch, J. P., Lewis, J. B., Greene, T., Rogers, N., Roth, D., & for the Modification of Diet in Renal Disease Study Group* (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-130-6-199903160-00002 · Cited by 15,079
Ford, E. S., Giles, W. H., & Dietz, W. H. (2002) · JAMA · doi:10.1001/jama.287.3.356 · Cited by 6,698
The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men
Lakka, H.-M. (2002) · JAMA · doi:10.1001/jama.288.21.2709 · Cited by 5,033
(1989) · PubMed · Cited by 3,139
THE ATHEROSCLEROSIS RISK IN COMMUNIT (ARIC) STUDY: DESIGN AND OBJECTIVES
THE ARIC INVESTIGATORS (1989) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a115184 · Cited by 2,924
Coresh, J., Astor, B. C., Greene, T., Eknoyan, G., & Levey, A. S. (2003) · American Journal of Kidney Diseases · doi:10.1053/ajkd.2003.50007 · Cited by 2,768
The Metabolic Syndrome and Chronic Kidney Disease in U.S. Adults
Chen, J., Muntner, P., Hamm, L. L., Jones, D. W., Batuman, V., Fonseca, V., Whelton, P. K., & He, J. (2004) · Annals of Internal Medicine · doi:10.7326/0003-4819-140-3-200402030-00007 · Cited by 1,359
Zatz, R., Dunn, B. R., Meyer, T. W., Anderson, S., Rennke, H. G., & Brenner, B. M. (1986) · Journal of Clinical Investigation · doi:10.1172/jci112521 · Cited by 1,209
Cited by
Items 501–600 of 719
Yamasaki, N., Sakurai, M., Kobayashi, J., Morikawa, Y., Kido, T., Naruse, Y., Nogawa, K., Suwazono, Y., Ishizaki, M., & Nakagawa, H. (2021) · Internal Medicine · doi:10.2169/internalmedicine.6235-20 · Cited by 7
[Practical management of oral antidiabetics in patients with renal disease].
Arroyo, R. A., Gonzalez Albarran, O., Honorato, J., Robles, N. R., Acha, J., de Álvaro, F., Gallego, F., Gomez Garcia, P., Lopez de la Torre, M., Castelao, A. M., et al. (2006) · PubMed · Cited by 7
Yamamoto, R., & Aso, Y. (2006) · Diabetes Care · doi:10.2337/diacare.29.04.06.dc05-2534 · Cited by 7
Renal Manifestations and Visceral Adiposity in Apparently Healthy Korean Women
Lee, J., Bae, U., Lee, D., Lee, H.-R., Shim, J., & Linton, J. A. (2008) · Kidney & Blood Pressure Research · doi:10.1159/000190787 · Cited by 7
Incidental Chronic Kidney Disease in Metabolic Syndrome
Chou, C., & Fang, T. (2010) · Tzu Chi Medical Journal · doi:10.1016/s1016-3190(10)60029-8 · Cited by 7
Williams, J. D., & Woods, H. F. (2006) · touchREVIEWS in Endocrinology · doi:10.17925/ee.2006.00.02.1p · Cited by 7
Gao, Q., Jia, S., Mo, X., & Zhang, H. (2024) · Chronic Diseases and Translational Medicine · doi:10.1002/cdt3.149 · Cited by 7
Sung, J., Hung, Y.-C., Wang, W.-R., Chu, C.-J., Lin, Y., Liu, K., Mahmudiono, T., & Chen, H. (2025) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2025.180066 · Cited by 6
Renal Disease in Metabolic Syndrome: the Hidden Role of Intrarenal Ischemia
Rodríguez-Rodríguez, R., Hornum, M., Rodríguez‐Rodríguez, A. E., Bevc, S., Trevisani, F., Fernández, G., Hojs, R., Fernández‐Fernández, B., Corona, C. M. C., Cruzado, J. M., et al. (2024) · Kidney International Reports · doi:10.1016/j.ekir.2024.02.1403 · Cited by 6
Physiological and Pathological Interactions Between Liver and Kidney
Watanabe, T. (2016) · Springer eBooks · doi:10.1007/978-4-431-55790-6_11 · Cited by 8
Impact of screening for metabolic syndrome on the evaluation of obese living kidney donors
Marcusa, D. P., Schaubel, D. E., Woodside, K. J., & Sung, R. S. (2017) · The American Journal of Surgery · doi:10.1016/j.amjsurg.2017.08.019 · Cited by 6
Maiwall, R., & Gupta, M. (2020) · Translational Gastroenterology and Hepatology · doi:10.21037/tgh.2019.10.11 · Cited by 6
Hong, D., Zhang, Y., Gao, B., Wang, J., Li, G., Wang, L., Zhang, L., & China National Survey of CKD Working Group (2015) · PLoS ONE · doi:10.1371/journal.pone.0132220 · Cited by 6
Moin, S., Gondal, G. M., & Bano, U. (2008) · PubMed · Cited by 7
Metabolic Syndrome in IgA Glomerulonephritis
Kaartinen, K., Syrjänen, J., Pörsti, I. H., Harmoinen, A. P. T., Huhtala, H., & Mustonen, J. T. (2014) · Nephron Extra · doi:10.1159/000365591 · Cited by 6
Chronic Kidney Disease and the Cardiometabolic Syndrome
Whaley‐Connell, A. T., & Sowers, J. R. (2006) · Journal of Clinical Hypertension · doi:10.1111/j.1524-6175.2006.05156.x · Cited by 6
Abdominal obesity is a risk factor for dysexecutive function in chronic kidney disease
Zammit, A. R., Katz, M. J., Derby, C. A., Bitzer, M., & Lipton, R. B. (2016) · Preventive Medicine Reports · doi:10.1016/j.pmedr.2016.06.007 · Cited by 6
Westenberg, L. B., van Londen, M., Zorgdrager, M., McAdams‐DeMarco, M., Segev, D. L., Bakker, S. J. L., Viddeleer, A. R., & Pol, R. A. (2024) · Scientific Reports · doi:10.1038/s41598-024-83320-8 · Cited by 5
Zarei, L., Rad, S. M., & Fard, A. A. (2019) · PubMed Central · doi:10.30466/vrf.2019.74079.1996 · Cited by 5
Eroglu, E. I., Kuxhaus, O., Jannasch, F., Nickel, D., & Schulze, M. B. (2024) · Metabolites · doi:10.3390/metabo14030172 · Cited by 5
Wen, J., Guo, C.-X., Lu, M., Lu, Y., Huang, Y., Liu, X., Li, Y., Huang, Z., Zhang, Y., & Yuan, H. (2016) · International Urology and Nephrology · doi:10.1007/s11255-015-1172-0 · Cited by 5
Srivastava, N., Singh, R. G., Usha, Kumar, A., & Singh, S. V. (2017) · Saudi Journal of Kidney Diseases and Transplantation · doi:10.4103/1319-2442.198114 · Cited by 6
Метаболічний синдром і ризик хронічної хвороби нирок
Melnyk, O. O. (2017) · KIDNEYS · doi:10.22141/2307-1257.6.2.2017.102785 · Cited by 7
Serum lipid profiles in patients with chronic kidney disease in a Saudi population
Aljabri, K. S. (2019) · Endocrinology&Metabolism International Journal · doi:10.15406/emij.2019.07.00239 · Cited by 5
Interactions between CKD and MetS and the Development of CVD
Aihara, K., Mogi, M., Shibata, R., Bishop‐Bailey, D., & Ma, X. L. (2011) · Cardiology Research and Practice · doi:10.4061/2011/878065 · Cited by 5
Metabolic Syndrome, CKD Progression, and Death: the Good, the Bad, and the Ugly
Lea, J. P. (2013) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.03960413 · Cited by 5
Major Risk Factors that lead to Onset End-Stage Renal Disease In Northern West Bank
Basheer, K. N. (2011) · Cited by 5
Cho, J. M., Han, K., Joo, K. W., Lee, S., Kim, Y., Cho, S., Huh, H., Kim, S. G., Kim, M., Kang, E., et al. (2024) · Kidney Research and Clinical Practice · doi:10.23876/j.krcp.23.135 · Cited by 5
Lee, H. J., Lee, Y. H., Kim, J. S., Jeong, K. H., Lee, J.-Y., Yoon, H. E., Na, K. R., Lee, D. R., Yang, J., Kim, M. S., et al. (2025) · Kidney Research and Clinical Practice · doi:10.23876/j.krcp.25.095 · Cited by 4
Tepebaşı, M. Y., Savran, M., Coşan, S., Taştan, Ş. A., & Aydın, B. (2024) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-024-03149-w · Cited by 4
Effect of probucol on insulin resistance in patients with non-diabetic chronic kidney disease.
Wang, R., Wei, R., Yang, Y., Wang, N., Huang, M., Cao, C.-M., Wang, Z., Cai, G., & Chen, X. (2015) · 老年心脏病学杂志:英文版 · doi:10.11909/j.issn.1671-5411.2015.05.020 · Cited by 4
Ali, N. H., Maher, F. T., & Al-Halbosiy, M. M. (2019) · Tikrit Journal of Pure Science · doi:10.25130/tjps.v24i3.370 · Cited by 4
Insulin Resistance is Associated with Subclinical Vascular Injury in Patients with a Kidney Disease
Adeva‐Andany, M. M., Fernández‐Fernández, C., Adeva-Contreras, L., Carneiro-Freire, N., Domínguez-Montero, A., & Mouriño-Bayolo, D. (2020) · Current Cardiology Reviews · doi:10.2174/1573403x16999201210200012 · Cited by 5
Lin, H. Y., Chang, L., Niu, S., Kuo, I., Yen, C., Shen, F., Chen, P., Chang, J., & Hung, C. (2023) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3618 · Cited by 4
Human apolipoprotein B transgenic SHR/NDmcr-cp rats show exacerbated kidney dysfunction
Asahina, M., Shimizu, F., Ohta, M., Takeyama, M., & Tozawa, R. (2015) · EXPERIMENTAL ANIMALS · doi:10.1538/expanim.15-0002 · Cited by 4
Age Related Metabolic Syndrome Among Hemodialysis Patients in Gorgan, Iran
Marjani, A., Moujerloo, M., & Hezarkhani, S. (2013) · The Open Biochemistry Journal · doi:10.2174/1874091x01307010015 · Cited by 4
Progression of Renal Dysfunction in Patients with Cardiovascular Disease
Hirata, Y., Kiyosue, A., Takahashi, M., Satonaka, H., Nagata, D., Sata, M., Suzuki, E., & Nagai, R. (2008) · Current Cardiology Reviews · doi:10.2174/157340308785160543 · Cited by 4
Kang, Y. H., Jeong, D. W., & Son, S. M. (2016) · Endocrinology and Metabolism · doi:10.3803/enm.2016.31.3.446 · Cited by 4
The latest ideas on the involvement of metabolic disorders in cardio-renal interrelation
Ivanov, A. O., & Shishkin, A. N. (2018) · Vestnik of Saint Petersburg University Medicine · doi:10.21638/11701/spbu11.2018.301 · Cited by 4
Valdez-Ortiz, R., Alemañy, G. M., Pérez-Navarro, M., Rosas-Herrera, A., Hinojosa-Heredia, H., & Fuentes-Mendez, L. D. C. (2021) · Nutrición Hospitalaria · doi:10.20960/nh.03646 · Cited by 4
Kitlinski, M., Giwercman, A., Christensson, A. G., Nilsson, P. M., & Elenkov, A. (2024) · Scientific Reports · doi:10.1038/s41598-024-58479-9 · Cited by 4
Korhonen, P. E., Aarnio, P. T. T., Vesalainen, R., Saaresranta, T., Kautiainen, H., Järvenpää, S. K., & Kantola, I. M. (2008) · Journal of Human Hypertension · doi:10.1038/jhh.2008.115 · Cited by 4
Youssef, S. M., Najah, M., Slimani, A., Khaldoun, B. H., Fadoua, N., Fadhel, N. M., & Slimane, M. N. (2013) · PPAR Research · doi:10.1155/2013/329862 · Cited by 8
Okada, S., Suzuki, A., Watanabe, H., Watanabe, T., & Aizawa, Y. (2010) · Journal of Obesity · doi:10.1155/2010/623593 · Cited by 4
Predictors of ischaemic heart disease in a Malaysian population with the metabolic syndrome
Yeow, T. P., Khir, A. S. M., Ismail, A. A.-S., Ismail, I. S., Musa, K. I., Khalid, B. A. K., Kamaruddin, N. A., Yaacob, N. A., Mustafa, N., Osman, A., et al. (2012) · Diabetic Medicine · doi:10.1111/j.1464-5491.2012.03741.x · Cited by 5
Renal function is impaired in normotensive chronic HCV patients: role of insulin resistance
Sciacqua, A., Perticone, M., Tassone, E. J., Cimellaro, A., Caroleo, B., Miceli, S., Andreucci, M., Licata, A., Sesti, G., & Perticone, F. (2015) · Internal and Emergency Medicine · doi:10.1007/s11739-015-1349-7 · Cited by 4
Metabolic syndrome in renal transplant recipients in Duhok Kidney Diseases Center
Saleem, Z. S. M. (2016) · Transplantation Reports · doi:10.1016/j.tpr.2016.06.001 · Cited by 4
Chu-Su, Y., Liu, C.-S., Chen, R., & Lin, C. (2016) · Biomedical Engineering Applications Basis and Communications · doi:10.4015/s1016237216500162 · Cited by 4
The Meaning of Cardiometabolic Risk in Hypertensive Patients
Ruilope, L. M., de la Sierra, A., Segura, J., & Donaire, J. A. G. (2007) · touchREVIEWS in Endocrinology · doi:10.17925/ee.2007.00.01.51 · Cited by 4
Workeneh, B., & Mitch, W. E. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-381462-3.00090-2 · Cited by 4
de Pinho, N. A. (2013) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.7.2013.tde-19092013-154219 · Cited by 4
Li, J., Zhou, L., Li, B., Tian, R., Hu, G., & Liu, Z. (2025) · American Journal of Translational Research · doi:10.62347/mxej5508 · Cited by 4
Chen, Y., Wang, K., Zhang, X., Yang, F., Liu, T., Cheng, A., Guan, Y., Zhong, J., Meng, J., Zhang, X., et al. (2025) · Renal Failure · doi:10.1080/0886022x.2025.2584751 · Cited by 3
A Hypercaloric Diet Induces Early Podocyte Damage in Aged, Non-Diabetic Rats
Seikrit, C., Lausberg, E., Buhl, E. M., Gáspár, R., Tábi, T., Heffer, M., Ducza, E., Sztojkov‐Ivanov, A., Seres, A. B., Szűcs, K. F., et al. (2021) · Cellular Physiology and Biochemistry · doi:10.33594/000000476 · Cited by 3
Yoon, H. J., Moon, A. E., Kim, K. G., Kim, M. C., & Jung, E. Y. (2017) · Journal of Renal Nutrition · doi:10.1053/j.jrn.2017.01.020 · Cited by 3
Renal Disease in Obesity, Metabolic Syndrome and Diabesity
Porrini, E., Navarro-Díaz, M., Rodríguez-Rodríguez, R., & SALIDO, E. C. (2018) · Springer eBooks · doi:10.1007/978-3-319-93521-8_5 · Cited by 3
Xu, W., Li, C., Ge, Q., Huang, Y., & Zhao, L. (2019) · Europe PMC (PubMed Central) · doi:10.12122/j.issn.1673-4254.2019.07.18 · Cited by 4
Febles, R. M., Miranda, D. M., Perera, C. C., Martin, L. D., Rodríguez‐Rodríguez, A. E., Martín, A. R. G., Báez, D. J. S., & Porrini, E. (2023) · The Nephron journals/Nephron journals · doi:10.1159/000531921 · Cited by 3
Sickle Cell Disease and Renal Disease
Abiodun, M., & Ojiefo, P. (2012) · InTech eBooks · doi:10.5772/25985 · Cited by 3
Chang, A. R., & Kramer, H. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-391934-2.00028-x · Cited by 3
Roy, H., Banerjee, P., Dan, S., Rahaman, M., Sengupta, M., & Bal, C. (2014) · Journal of Drug Delivery and Therapeutics · doi:10.22270/jddt.v4i1.762 · Cited by 3
Association of Serum Cystatin C with Metabolic Syndrome and Its Related Components in Korean Adults
Kim, S. Y., Song, S. H., Jeon, Y. K., Kim, J. R., Bae, J. H., Kim, S. S., Lee, S. H., Son, S. M., Kim, I. J., Kim, Y. K., et al. (2008) · Korean Diabetes Journal · doi:10.4093/kdj.2008.32.5.409 · Cited by 3
Senior, P. A. (2008) · Diabetic Medicine · doi:10.1111/j.1464-5491.2008.02624.x · Cited by 3
Síndrome metabólico y enfermedad renal
Molina, P. (2010) · Revista Médica Clínica Las Condes · doi:10.1016/s0716-8640(10)70570-8 · Cited by 7
Halimi, J. (2014) · Journal of Diabetes & Metabolism · doi:10.4172/2155-6156.1000387 · Cited by 3
Metabolic Syndrome in Hypertension – Treatment Challenges and Goals
de la Sierra, A. (2009) · European Cardiology Review · doi:10.15420/ecr.2009.5.2.40 · Cited by 3
Metabolic syndrome and kidney: nephroprotection and reduction of cardiovascular risk
Nedogoda, S. V., Chumachek, E. V., Цома, В. В., Salasyuk, A. S., Смирнова, В. О., Hripaeva, V. Y., Палашкин, Р. В., & Popova, E. A. (2018) · Arterial’naya Gipertenziya (Arterial Hypertension) · doi:10.18705/1607-419x-2018-24-3-369-378 · Cited by 3
Cardiac biomarkers and chronic renal diseases
Valocikova, I., Kristofová, B., & Valočík, G. (2008) · Bratislavské lekárske listy/Bratislava medical journal · doi:10.1007/bf03657064 · Cited by 3
Chen, J., & Townsend, R. R. (2007) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.8.13.2001 · Cited by 3
Gandhi, T., Patel, A., & Purohit, M. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-90583-1.00034-9 · Cited by 4
Guo, Q., Chen, M., Yu, Y., Li, P., Huang, X., Shen, L., Long, C., Liu, X., Lin, T., He, D., et al. (2024) · Pediatric Discovery · doi:10.1002/pdi3.93 · Cited by 2
Ware, S. K. (2007) · Food science and technology · doi:10.1201/9781420006902.ch46 · Cited by 2
Abraham, J. D., & Beddhu, S. (2014) · Humana Press eBooks · doi:10.1007/978-1-62703-770-9_20 · Cited by 2
Nutrition and Chronic Kidney Disease
Chen, X., & Beddhu, S. (2014) · Springer eBooks · doi:10.1007/978-1-4939-1929-1_16 · Cited by 4
Mohsin, N., Faure, M., Szwarc, I., Pernin, V., & Mourad, G. (2013) · Transplantation Proceedings · doi:10.1016/j.transproceed.2013.08.094 · Cited by 2
Vigil, L., Goday, A., Gabriel, R., Ascaso, J. F., Franch‐Nadal, J., & Ortega, R. (2011) · International Journal of Clinical Medicine · doi:10.4236/ijcm.2011.24063 · Cited by 2
Improvement of Kidney Function Following Bariatric Surgery: Hope or Illusion?
Favrè, G., Schneck, A., Anty, R., Esnault, V. L. M., & Iannelli, A. (2015) · Obesity Surgery · doi:10.1007/s11695-015-1819-z · Cited by 2
Effects of Metabolic Syndrome on Chronic Kidney Disease
Cho, I., Kim, Y., Chae, Y., Kim, T.-W., Yun, S. J., Lee, S., Kim, W., & Kim, Y. (2009) · Korean journal of urology · doi:10.4111/kju.2009.50.3.261 · Cited by 2
Chapter 11 High Blood Pressure
Bautista, L. E. (2010) · American Public Health Association eBooks · doi:10.2105/9780875531922ch11 · Cited by 2
Siméon, S., Massy, Z. A., Højlund, K., Lalic, K. S., Porcellati, F., Dekker, J., Petrie, J. R., Currie, G. E., & Balkau, B. (2018) · BMC Nephrology · doi:10.1186/s12882-018-0918-1 · Cited by 3
Kim, H., Joo, H. J., Lim, W., Seo, J., Kim, S., Zo, J., Lim, D., & Kim, M. (2020) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2020.0026 · Cited by 2
Sinha, S. K., Shaheen, M. A., Singh, V. R., Rajavashisth, T. B., Pan, D., Sun, L., Norris, K. C., & Nicholas, S. B. (2020) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2019.0121 · Cited by 2
Shields, C. A., Poudel, B., McPherson, K. C., Brown, A. K., Ekperikpe, U. S., Browning, E., Sutton, L., Cornelius, D. C., & Williams, J. M. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.566403 · Cited by 2
Effects of nutritional status and changes in nutrient intake on renal function
Narasaki, Y., & Rhee, C. M. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-818540-7.00025-2 · Cited by 3
Özkan, E., Gök, M., Çetinkaya, H., Kaplan, M., & Sahin, G. M. (2023) · International Urology and Nephrology · doi:10.1007/s11255-023-03536-x · Cited by 2
Liao, M.-C., Lo, C., Pang, Y., Yang, W., Su, K., Zhao, X. C., Miyata, K. N., Peng, J., Ingelfinger, J. R., Chan, J. S. D., et al. (2024) · Translational research · doi:10.1016/j.trsl.2024.01.002 · Cited by 2
Williams, M. E., Magerowski, G., & Blackburn, G. L. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-391934-2.00029-1 · Cited by 2
Alterations induced by juvenile obesity on the renal tissue of nutrient restricted offspring
Fainberg, H. P. (2010) · Nottingham ePrints (University of Nottingham) · Cited by 2
Long-term consequences of differences in early growth : epidemiological aspects
Euser, A. M. (2009) · Leiden Repository (Leiden University) · Cited by 2
Renal functions in patients with metabolic syndrome
Augusthy, A., Sahu, S., Jeppu, A. K., & Jawalekar, S. (2018) · International Journal of Medical Research and Review · doi:10.17511/ijmrr.2018.i08.02 · Cited by 1
Slowing Chronic Kidney Disease Progression
Sanghi, P., & Brahmbhatt, Y. G. (2021) · Springer eBooks · doi:10.1007/978-3-030-83082-3_4 · Cited by 1
Xie, J., Zheng, B., Sihai, W., Guoming, S., & Zhaohui, F. (2023) · PubMed Central · doi:10.19852/j.cnki.jtcm.20230124.001 · Cited by 1
Lee, Y. H., Kim, D. K., Kim, J. S., Jeong, S. J., Jeong, K. H., & Hwang, H. S. (2025) · Frontiers in Nutrition · doi:10.3389/fnut.2025.1652372 · Cited by 2
Zhang, L., Hao, Z.-Y., Li, M. T., Liu, J., Su, M., Zhang, Z.-H., Yue, S., Liu, Y.-Y., Li, C., & Ma, J. X. (2026) · BMC Geriatrics · doi:10.1186/s12877-026-07918-5 · Cited by 1
Yang, H., Seo, Y. G., & Han, N. (2026) · Scientific Reports · doi:10.1038/s41598-026-63327-z · Cited by 1
World Congress on the Insulin Resistance Syndrome, 2009
Bloomgarden, Z. T. (2010) · Diabetes Care · doi:10.2337/dc10-zb09 · Cited by 1
Aboalsamh, G. A. (2015) · Scholarship@Western (Western University) · Cited by 1
de la Sierra, A. (2008) · High Blood Pressure & Cardiovascular Prevention · doi:10.2165/00151642-200815020-00003 · Cited by 2
Metabolic Syndrome Associated Kidney Damage
Zou, H., Wang, Y., Zou, G., & Wu, J. (2011) · InTech eBooks · doi:10.5772/25048 · Cited by 1
The cardiometabolic syndrome and chronic kidney disease
Yerram, P., Karuparthi, P. R., Saab, G., & Whaley‐Connell, A. T. (2008) · Current Cardiovascular Risk Reports · doi:10.1007/s12170-008-0019-y · Cited by 1
Metadata
- Authors
- Kurella, M., Lo, J. C., & Chertow, G. M.
- Venue
- Journal of the American Society of Nephrology
- Published
- 2005-07
- Volume
- 16
- Issue
- 7
- Pages
- 2134-2140
- ISSN
- 1046-6673 (ISSN-L)
- OpenAlex
- W2107279414
- Cited by
- 709
- References
- 43
- Citations by year
- 2026: 5 · 2025: 18 · 2024: 23 · 2023: 21 · 2022: 24 · 2021: 25 · 2020: 34 · 2019: 30 · 2018: 29 · 2017: 24 · 2016: 31 · 2015: 35 · 2014: 45 · 2013: 42 · 2012: 42
- FWCI
- 27.66
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of the American Society of Nephrology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Diabetes and Digestive and Kidney Diseases (N01DK12450)
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (K12AR047659, K12 AR47659)
- Topics
- Health Sciences › Medicine › Nephrology › Chronic Kidney Disease and Diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
- Keywords
- metabolic syndrome, chronic kidney disease, non-diabetic adults, estimated glomerular filtration rate, incident CKD risk, Atherosclerosis Risk in Communities Study, diabetes mellitus, hypertension, cardiovascular risk factors
- MeSH terms
- Chronic Disease, Diabetes Mellitus, Female, Humans, Kidney Diseases, Male, Middle Aged, Risk Factors, Incidence, Metabolic Syndrome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.